Immunological effect of early extra MMR immunization in infants between 6 and 12 months of age in an outbreak setting - Immunological effect of early extra MMR immunization (EMI)

RIVM0 个研究点开始时间: 2013年8月8日最近更新: 2013年9月23日

适应症

试验速览

暂无简介。

•Group 1: infants receiving (or having received) MMR-0 between 6-12 months of age and who are about to receive the MMR-1 at 14 months of age
•Group 2: infants not receiving MMR-0 and who are about to receive the MMR-1 at 14 months of age
•Are the trial subjects under 18? yes
•Number of subjects for this age range: 100
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Encountered measles infection earlier in life
•Receiving immunosuppressive medication
•Presence of a serious disease that requires medical care that can interfere with the results of the study
•Known or expected allergy/hypersensitivity against one of the vaccine ingredients
•Known or suspected immunological disorder
•Bleeding disorders

发起方

RIVM